GlassScriptPhysician profile
Ashley Bellamy
NPI 1952798613
$881.11
in general payments reported to CMS, 2019-2025
15 companies · $25.09 in 2025
The $25.09 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.00 · 2021: $123 · 2022: $280 · 2023: $299 · 2024: $140 · 2025: $25.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $464.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $184.14 | 2022-2023 | Lo Loestrin Fe, Orilissa, Liletta |
| Shield Therapeutics INC | $135.26 | 2023-2024 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $108.43 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $73.95 | 2020-2025 | Gardasil 9 |
| Astellas Pharma US INC | $66.50 | 2024 | Veozah |
| Therapeuticsmd, INC. | $45.88 | 2021-2022 | |
| Avion Pharmaceuticals | $43.48 | 2021-2022 | |
| Renovia INC | $41.37 | 2021 | |
| Sage Therapeutics, LLC | $39.44 | 2022-2023 | |
| Pfizer INC. | $33.02 | 2021-2024 | |
| Organon LLC | $29.39 | 2022 | |
| Aspira Women'S Health INC | $26.26 | 2021 | |
| Evofem Biosciences, INC. | $22.02 | 2023 | Phexxi |
| Coopersurgical, INC. | $16.18 | 2023 | Endosee |
| Novo Nordisk INC | $15.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Bellamy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.